Macquarie Group LTD Guardant Health, Inc. Transaction History

Macquarie Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $46,716 - $65,270	-1,070 Reduced 49.68%	1,084 $116,000
Q4 2021 Feb 11, 2022	SELL	$88.71 - $120.43 $91.6 Million - $124 Million	-1,032,758 Reduced 99.79%	2,154 $215,000
Q3 2021 Nov 12, 2021	BUY	$98.77 - $132.17 $21.1 Million - $28.2 Million	213,241 Added 25.95%	1,034,912 $129 Million
Q2 2021 Aug 13, 2021	BUY	$109.77 - $165.68 $89.9 Million - $136 Million	819,274 Added 34179.14%	821,671 $102 Million
Q1 2021 May 14, 2021	SELL	$127.04 - $179.1 $39,382 - $55,521	-310 Reduced 11.45%	2,397 $366,000
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $59,975 - $81,558	600 Added 28.48%	2,707 $349,000
Q2 2020 Aug 11, 2020	BUY	$60.49 - $97.5 $127,452 - $205,432	2,107 New	2,107 $171,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.